Basic Information
| LncRNA/CircRNA Name | lncRNA-CLMAT3 |
| Synonyms | CTB-113P19.1, CLMAT3 |
| Region | GRCh38_5:151676945-151724782 |
| Ensemble | ENSG00000249035 |
| Refseq | NR_109873 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | Microarray, qPCR etc. |
| Sample | CRC tissues |
| Expression Pattern | up-regulated |
| Function Description | The levels of lncRNA-CLMAT3 in the cancerous tissues were 2.26-fold higher than those in the normal colorectal tissues. In addition, lncRNA-CLMAT3 expression was significantly higher in the patients with liver metastasis than in those without liver metastasis and in the patients with lymph node metastasis than in those without lymph node metastasis. |
| Pubmed ID | 26050227 |
| Year | 2015 |
| Title | Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis. |
External Links
| Links for lncRNA-CLMAT3 | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |